Collegium Pharmaceutical Inc (COLL)
Deferred Revenue
$667.00K
Quarterly · Period ending: · USD
COLL Deferred Revenue
Latest reported$667.00Kperiod ending
Latest reported$667.00Kperiod ending
COLL Quarterly Deferred Revenue ($0.00 → $667.00K)
Quarterly deferred revenue
High-resolution chart · PNG
COLL deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 667,000 | |
| 667,000 | |
| 667,000 | |
| 667,000 | |
| 0 | |
| 10,000,000 | |
| 10,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 171,642,000 | |
| -32,193,000 | |
| 151,387,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10,361,000 | |
| 8,695,000 | |
| 4,944,000 | |
| 3,938,000 | |
| 3,926,000 | |
| 0 | |
| -9,548,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |